Results 201 to 204 of about 3,126,313 (204)

Human medicines European public assessment report (EPAR): Anagrelide Mylan, anagrelide, Thrombocythemia, Essential, Date of authorisation: 15/02/2018, Revision: 1, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Xagrid, anagrelide, Thrombocythemia, Essential, Date of authorisation: 15/11/2004, Revision: 33, Status: Authorised

Case Medical Research, 2018

semanticscholar   +1 more source

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Cancer Cell, 2005
R. Levine, M. Wadleigh, J. Cools, B. Ebert, G. Wernig, B. Huntly, T. Boggon, I. Wlodarska, Jennifer J. Clark, Sandra A. Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, S. Gabriel, T. Mercher, A. D’Andrea, S. Fröhling, K. Döhner, P. Marynen, P. Vandenberghe, R. Mesa, A. Tefferi, J. Griffin, M. Eck, W. Sellers, M. Meyerson, T. Golub, Stephanie J. Lee, D. Gilliland   +28 more
semanticscholar   +1 more source

Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera

International journal of hematology, 2020
I. Krečak, H. Holik, M. Martina, I. Zekanović, B. Coha, V. Gverić-Krečak   +5 more
semanticscholar   +1 more source